Type I PRMT Inhibition Protects Against C9ORF72 Arginine-Rich Dipeptide Repeat Toxicity

por Premasiri, Alan S., Gill, Anna L., Vieira, Fernando G.
Publicado 2020

Hypothesis and Theory: Roles of Arginine Methylation in C9orf72-Mediated ALS and FTD

por Gill, Anna L., Premasiri, Alan S., Vieira, Fernando G.
Publicado 2021

Reduced C9orf72 expression exacerbates polyGR toxicity in patient iPSC-derived motor neurons and a Type I protein arginine methyltransferase inhibitor reduces that toxicity

por Dane, Therese L., Gill, Anna L., Vieira, Fernando G., Denton, Kyle R.
Publicado 2023

Primary Neurons and Differentiated NSC-34 Cells Are More Susceptible to Arginine-Rich ALS Dipeptide Repeat Protein-Associated Toxicity than Non-Differentiated NSC-34 and CHO Cells

por Gill, Anna L., Wang, Monica Z., Levine, Beth, Premasiri, Alan, Vieira, Fernando G.
Publicado 2019